Original
Acetato de glatirámero: reacciones adversas no comunes
Glatiramer acetate: Uncommon adverse reactions
Miguel Merchan-Ruiz
, Judit Guerrero-Clemente, Miguel Ángel Robles-Sánchez, Lluis Ramió-Torrentà
Autor para correspondencia
Unidad de Neuroimmunología y Esclerosis Múltiple, Institut d’Investigació Biomèdica de Girona, Hospital Universitari de Girona Dr. Josep Trueta, Gerona, España
Leído
6386
Vecesse ha leído el artículo
2208
Total PDF
4178
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 19 | 8 | 27 |
| 2025 11 | 47 | 18 | 65 |
| 2025 10 | 39 | 6 | 45 |
| 2025 9 | 35 | 20 | 55 |
| 2025 8 | 29 | 9 | 38 |
| 2025 7 | 37 | 9 | 46 |
| 2025 6 | 46 | 7 | 53 |
| 2025 5 | 42 | 8 | 50 |
| 2025 4 | 40 | 3 | 43 |
| 2025 3 | 47 | 6 | 53 |
| 2025 2 | 37 | 6 | 43 |
| 2025 1 | 49 | 8 | 57 |
| 2024 12 | 59 | 6 | 65 |
| 2024 11 | 67 | 3 | 70 |
| 2024 10 | 67 | 7 | 74 |
| 2024 9 | 66 | 15 | 81 |
| 2024 8 | 52 | 9 | 61 |
| 2024 7 | 37 | 2 | 39 |
| 2024 6 | 46 | 6 | 52 |
| 2024 5 | 69 | 7 | 76 |
| 2024 4 | 69 | 3 | 72 |
| 2024 3 | 40 | 5 | 45 |
| 2024 2 | 52 | 4 | 56 |
| 2024 1 | 52 | 1 | 53 |
| 2023 12 | 46 | 3 | 49 |
| 2023 11 | 59 | 4 | 63 |
| 2023 10 | 51 | 5 | 56 |
| 2023 9 | 31 | 0 | 31 |
| 2023 8 | 23 | 3 | 26 |
| 2023 7 | 37 | 1 | 38 |
| 2023 6 | 32 | 3 | 35 |
| 2023 5 | 38 | 7 | 45 |
| 2023 4 | 32 | 4 | 36 |
| 2023 3 | 56 | 8 | 64 |
| 2023 2 | 29 | 3 | 32 |
| 2022 1 | 25 | 2 | 27 |
| 2022 12 | 27 | 6 | 33 |
| 2022 11 | 34 | 4 | 38 |
| 2022 10 | 17 | 9 | 26 |
| 2022 9 | 31 | 8 | 39 |
| 2022 8 | 33 | 9 | 42 |
| 2022 7 | 27 | 4 | 31 |
| 2022 6 | 16 | 3 | 19 |
| 2022 5 | 15 | 5 | 20 |
| 2022 4 | 23 | 15 | 38 |
| 2022 3 | 50 | 10 | 60 |
| 2022 2 | 20 | 4 | 24 |
| 2021 1 | 39 | 7 | 46 |
| 2021 12 | 26 | 10 | 36 |
| 2021 11 | 42 | 11 | 53 |
| 2021 10 | 28 | 7 | 35 |
| 2021 9 | 23 | 7 | 30 |
| 2021 8 | 24 | 13 | 37 |
| 2021 7 | 13 | 9 | 22 |
| 2021 6 | 13 | 8 | 21 |
| 2021 5 | 16 | 6 | 22 |
| 2021 4 | 49 | 18 | 67 |
| 2021 3 | 31 | 3 | 34 |
| 2021 2 | 18 | 12 | 30 |
| 2020 1 | 26 | 9 | 35 |
| 2020 12 | 23 | 9 | 32 |
| 2020 11 | 20 | 3 | 23 |
| 2020 10 | 17 | 4 | 21 |
| 2020 9 | 17 | 6 | 23 |
| 2020 8 | 13 | 5 | 18 |
| 2020 7 | 10 | 1 | 11 |
| 2020 6 | 6 | 3 | 9 |
| 2020 5 | 19 | 2 | 21 |
| 2020 4 | 18 | 1 | 19 |
| 2020 3 | 20 | 8 | 28 |
| 2020 2 | 17 | 2 | 19 |
| 2020 1 | 9 | 6 | 15 |
| 2019 12 | 12 | 14 | 26 |
| 2019 11 | 12 | 12 | 24 |
| 2019 10 | 20 | 6 | 26 |
| 2019 9 | 27 | 6 | 33 |
| 2019 8 | 20 | 10 | 30 |
| 2019 7 | 36 | 25 | 61 |
| 2019 6 | 73 | 48 | 121 |
| 2019 5 | 134 | 64 | 198 |
| 2019 4 | 76 | 56 | 132 |
| 2019 3 | 12 | 12 | 24 |
| 2019 2 | 13 | 20 | 33 |
| 2019 1 | 17 | 14 | 31 |
| 2018 12 | 14 | 12 | 26 |
| 2018 11 | 14 | 15 | 29 |
| 2018 10 | 24 | 15 | 39 |
| 2018 9 | 10 | 18 | 28 |
| 2018 8 | 15 | 26 | 41 |
| 2018 7 | 20 | 20 | 40 |
| 2018 6 | 4 | 18 | 22 |
| 2018 5 | 8 | 25 | 33 |
| 2018 4 | 6 | 23 | 29 |
| 2018 3 | 13 | 13 | 26 |
| 2018 2 | 7 | 10 | 17 |
| 2018 1 | 5 | 17 | 22 |
| 2017 12 | 6 | 9 | 15 |
| 2017 11 | 12 | 16 | 28 |
| 2017 10 | 12 | 18 | 30 |
| 2017 9 | 18 | 25 | 43 |
| 2017 8 | 12 | 32 | 44 |
| 2017 7 | 14 | 41 | 55 |
| 2017 6 | 15 | 21 | 36 |
| 2017 5 | 21 | 32 | 53 |
| 2017 4 | 20 | 27 | 47 |
| 2017 3 | 28 | 34 | 62 |
| 2017 2 | 23 | 39 | 62 |
| 2016 1 | 22 | 9 | 31 |
| 2016 12 | 34 | 20 | 54 |
| 2016 11 | 43 | 43 | 86 |
| 2016 10 | 43 | 37 | 80 |
| 2016 9 | 34 | 47 | 81 |
| 2016 8 | 49 | 38 | 87 |
| 2016 7 | 36 | 19 | 55 |
| 2016 6 | 36 | 64 | 100 |
| 2016 5 | 25 | 49 | 74 |
| 2016 4 | 18 | 56 | 74 |
| 2016 3 | 35 | 47 | 82 |
| 2016 2 | 19 | 33 | 52 |
| 2015 1 | 16 | 39 | 55 |
| 2015 12 | 36 | 40 | 76 |
| 2015 11 | 26 | 54 | 80 |
| 2015 10 | 40 | 83 | 123 |
| 2015 9 | 23 | 41 | 64 |
| 2015 8 | 38 | 26 | 64 |
| 2015 7 | 21 | 30 | 51 |
| 2015 6 | 24 | 32 | 56 |
| 2015 5 | 38 | 29 | 67 |
| 2015 4 | 47 | 32 | 79 |
| 2015 3 | 39 | 23 | 62 |
| 2015 2 | 77 | 15 | 92 |
| 2015 1 | 58 | 19 | 77 |
| 2014 12 | 54 | 18 | 72 |
| 2014 11 | 42 | 6 | 48 |
Mostrar todo